Delta 40 p 53 suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells
Delta 40 p 53 suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells
复制标题
Delta 40 p 53 抑制肿瘤细胞增殖并诱导肝细胞癌细胞衰老
DOI:
--
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
M. Yoneda
中科院分区:
文献类型:
--
作者:
Akinobu Ota;Haruhisa Nakao;Yumi Sawada;S. Karnan;M. Wahiduzzaman;Tadahisa Inoue;Yuji Kobayashi;Takaya Yamamoto;Norimitsu Ishii;Tomohiko Ohashi;Y. Nakade;Ken Sato;K. Itoh;H. Konishi;Y. Hosokawa;M. Yoneda
Splicing isoforms of certain genes impact on genetic biodiversity in mammals. The tumor suppressor TP53 gene plays an important role in the regulation of tumorigenesis in hepatocellular carcinoma (HCC). Delta40p53 (Δ40p53) is a naturally occurring p53 isoform that lacks Nterminal transactivation domain, yet little is known about the role of Δ40p53 in the development of HCC. Here, we first report the role of Δ40p53 in HCC cell lines. In the p53 cell clones, clonogenic activity and cell survival dramatically decreased, while the percentage of SA-β-gal positive cells as well as p21 expression significantly increased. These observations were clearly attenuated in the p53 cell clones after Δ40p53 knockdown. In addition, exogenous Δ40p53 expression significantly suppressed cell growth in TP53, TP53, and TP53 HCC cells. Notably, Δ40p53-induced tumor suppressor activity was markedly attenuated in cells expressing the hot-spot mutant, Δ40p53/R175H, which lacks transcriptional activity of p53. Moreover, Δ40p53 expression was associated with increased full-length p53 protein expression. These findings enhance the understanding of the molecular pathogenesis of HCC; Δ40p53 acts as an important tumor suppressor in HCC cells. Jo ur na l o f C el l S ci en ce • A dv an ce a rt ic le INTRODUCTION Hepatocellular carcinoma (HCC), one of the most frequent malignancies worldwide (Lozano et al., 2012), commonly develops in response to continuous microenvironmental stresses, including chemical exposure, chronic inflammation from hepatitis viral infection, tissue remodeling in the liver, and a high fat diet (Liu et al., 2014; Nishida and Goel, 2011). As an initiating oncogenic event in HCC, the disruption of the p53 tumor suppressor gene has been shown to be closely associated with hepatocarcinogenesis. Deletion of the Trp53 gene resulted in the development of liver tumors in a significant number of mice (Katz et al., 2012; Morris et al., 2012), while restoring p53 in a murine liver carcinoma model limited tumor cell growth by mediating cellular senescence (Xue et al., 2007). Thus, accumulating evidence implicates TP53 gene dysfunction in the development of HCC. In general, splicing isoforms of certain genes play an important role in biodiversity. It has known that TP53 gene potentially encodes at least twelve p53 isoforms, in which four different N-terminal p53 forms (full length, Δ40, Δ133, and Δ160) are combined with three different Cterminal domains (alpha, beta, and gamma) (Marcel et al, 2012). Full-length (FL)-p53 protein (also called TAp53alpha) is the canonical p53 protein, while Δ40p53alpha (also known as p53/47), a p53 isoform that lacks the 39 N-terminal amino acids corresponding to the first transactivation domain (TAD-I) of FL-p53, is translated from an in-frame second AUG at nucleotides 252-254 of p53 mRNA through a second internal ribosome entry site (Olivares-Illana and Fåhraeus et al., 2010; Wei et al., 2012). Recent studies demonstrated the biological effects of Δ40p53alpha in both humans and mice. Transgenic mice overexpressing p44, the mouse homolog of Δ40p53alpha, showed obvious signs of aging and a shorter lifespan (Maier et al., 2004; Qian and Chen, 2013). It has been reported that Δ40p53alpha exerts anti-cancer properties in human lung cancer and melanoma cells (Yin et al., 2002; Candeias et al., 2006; Takahashi et al., 2014). In contrast, Jo ur na l o f C el l S ci en ce • A dv an ce a rt ic le Courtois et al reported that Δ40p53alpha counteracts growth suppression via FL-p53 in mouse fibroblasts (Courtois et al., 2002). Thus, the biological function of Δ40p53alpha potentially varies according to cell type. Although accumulating evidence has implicated Δ40p53alpha in aging and/or tumor suppression, little is known about the involvement of Δ40p53alpha in the development of HCC. In the present study, we are the first to report the tumor suppressor role of Δ40p53alpha (here after called Δ40p53) in the development of HCC. We also discuss a possible molecular mechanism underlying Δ40p53-induced tumor suppression and senescence. Jo ur na l o f C el l S ci en ce • A dv an ce a rt ic le MATERIALS AND METHODS
影响因子:
29.4
作者:
Katz, Sarah-Fee;Lechel, Andre;Rudolph, K. Lenhard
通讯作者:
Rudolph, K. Lenhard